VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: A morphometric study

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 4, 2011, Pages 1269-1275

  Stinga A C ^a   Mǎrgǎritescu, Otilia ^b   Stîngǎ, Alina Simona ^a   Pirici, D ^a   Ciurea, Raluca ^a   Bunget, Adina ^a   Cruce, M ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Emergency County Hospital   (Romania)

Author keywords

Immunohistochemistry; Oral squamous cell carcinoma; VEGFR1; VEGFR2

Indexed keywords

VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84855500553     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, IARC Cancer Base No. 5, Version 2.0, IARC Press, Lyon, 2004, http://www-dep.iarc.fr/.
2. Li C, Shintani S, Terakado N, Klosek SK, Ishikawa T, Nakashiro K, Hamakawa H, Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas, Int J Oral Maxillofac Surg, 2005, 34(5):559-565.
3. Johnstone S, Logan RM, Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma, Int J Oral Maxillofac Surg, 2007, 36(3):263-266.
4. Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R, Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis, Clin Cancer Res, 2005, 11(6):2272-2284.
5. Joo YH, Jung CK, Kim MS, Sun DI, Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer, Otolaryngol Head Neck Surg, 2009, 140(4):512-518.
6. Kim SH, Cho NH, Kim K, Lee JS, Koo BS, Kim JH, Chang JH, Choi EC, Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, J Surg Oncol, 2006, 93(4):330-337.
7. Kyzas PA, Stefanou D, Agnantis NJ, Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip, Oral Oncol, 2004, 40(9):941-947.
8. Maeda T, Matsumura S, Hiranuma H, Jikko A, Furukawa S, Ishida T, Fuchihata H, Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status, J Clin Pathol, 1998, 51(10):771-775.
9. Shang ZJ, Li JR, Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression, J Oral Pathol Med, 2005, 34(3):134-139.
10. Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H, Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma, Oral Oncol, 2004, 40(1):13-20.
11. Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG, Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma, J Clin Oncol, 2000, 18(10):2046-2052.
12. Margaritescu C, Pirici D, Stînga A, Simionescu C, Raica M, Mogoanta L, Stepan A, Ribatti D, VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study, Clin Exp Med, 2010, 10(4):209-214.
13. Uehara M, Sano K, Ikeda H, Sekine J, Irie A, Yokota T, Tobita T, Ohba S, Inokuchi T, Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma, Oral Oncol, 2004, 40(3):321-325.
14. Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD, A potential autocrine role for vascular endothelial growth factor in prostate cancer, Cancer Res, 2002, 62(3):854-859.
15. Tsuchiya N, Sato K, Akao T, Kakinuma H, Sasaki R, Shimoda N, Satoh S, Habuchi T, Ogawa O, Kato T, Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma, Tohoku J Exp Med, 2001, 195(2):101-113.
16. Zhang H, Wu J, Meng L, Shou CC, Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells, World J Gastroenterol, 2002, 8(6):994-998.
17. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H, Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma, Anticancer Res, 2002, 22(6C):3977-3984.
18. Talvensaari-Mattila A, Soini Y, Santala M, VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma, Tumour Biol, 2005, 26(2):81-87.
19. Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ, The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma, Int J Cancer, 2006, 119(7):1519-1529.
20. Chung GG, Yoon HH, Zerkowski MP, Ghosh S, Thomas L, Harigopal M, Charette LA, Salem RR, Camp RL, Rimm DL, Burtness BA, Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray, Cancer, 2006, 106(8):1677-1684.
21. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK, Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma, J Natl Cancer Inst, 1995, 87(7):506-516.
22. Dales JP, Garcia S, Bonnier P, Duffaud F, Carpentier S, Djemli A, Ramuz O, Andrac L, Lavaut M, Allasia C, Charpin C, Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma, Ann Pathol, 2003, 23(4):297-305.
23. Neuchrist C, Erovic BM, Handisurya A, Steiner GE, Rockwell P, Gedlicka C, Burian M, Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck, Laryngoscope, 2001, 111(10):1834-1841.
24. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2, Mod Pathol, 2005, 18(4):485-494.
25. Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL, Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma, Arch Otolaryngol Head Neck Surg, 2003, 129(8):882-888.
26. Sato H, Takeda Y, VEGFR2 expression and relationship between tumor neovascularization and histologic characteristics in oral squamous cell carcinoma, J Oral Sci, 2009, 51(4):551-557.
27. Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nör JE, VEGFdependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2, Cell Death Differ, 2010, 17(3):499-512.